| Use of rabbit eyes in pharmacokinetic studies of intraocular drugs SJ Ahn, HK Hong, YM Na, SJ Park, J Ahn, J Oh, JY Chung, KH Park, ... Journal of visualized experiments: JoVE, 53878, 2016 | 71 | 2016 |
| Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic … J Oh, H Chung, SI Park, SJ Yi, K Jang, AH Kim, J Yoon, JY Cho, SH Yoon, ... Diabetes, Obesity and Metabolism 18 (1), 104-108, 2016 | 44 | 2016 |
| Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects J Sunwoo, SC Ji, J Oh, MS Ban, JY Nam, B Kim, GS Song, KS Yu, IJ Jang, ... Alimentary Pharmacology & Therapeutics 52 (11-12), 1640-1647, 2020 | 35 | 2020 |
| Effects of CYP2C19 genetic polymorphisms on PK/PD responses of omeprazole in Korean healthy volunteers S Park, YJ Hyun, YR Kim, JH Lee, S Ryu, JM Kim, WY Oh, HS Na, JG Lee, ... Journal of Korean medical science 32 (5), 729-736, 2017 | 33 | 2017 |
| A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: an open-label, parallel group, randomized clinical study H Chung, J Oh, SH Yoon, KS Yu, JY Cho, JY Chung PLoS One 13 (1), e0191258, 2018 | 30 | 2018 |
| Pharmacokinetics of second-line antituberculosis drugs after multiple administrations in healthy volunteers SI Park, J Oh, K Jang, J Yoon, SJ Moon, JS Park, JH Lee, J Song, IJ Jang, ... Antimicrobial Agents and Chemotherapy 59 (8), 4429-4435, 2015 | 26 | 2015 |
| The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans J Oh, SH Lee, H Lee, JY Cho, SH Yoon, IJ Jang, KS Yu, KS Lim PLoS One 12 (4), e0176320, 2017 | 24 | 2017 |
| Pharmacokinetic characteristics and limited sampling strategies for therapeutic drug monitoring of colistin in patients with multidrug-resistant gram-negative bacterial infections EJ Kim, J Oh, K Lee, KS Yu, JY Chung, JH Hwang, EY Nam, HS Kim, ... Therapeutic drug monitoring 41 (1), 102-106, 2019 | 23 | 2019 |
| Clinical evaluation of digital therapeutics: present and future KY Huh, J Oh, SH Lee, KS Yu Healthcare Informatics Research 28 (3), 188-197, 2022 | 22 | 2022 |
| Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects S Rhee, YJ Choi, SH Lee, J Oh, SJ Kim, SH Yoon, JY Cho, KS Yu Drug Design, Development and Therapy, 2525-2534, 2016 | 18 | 2016 |
| Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects I Hwang, SC Ji, J Oh, H Kim, H Cha, J Kim, CS Lee, KS Yu, SH Lee Alimentary Pharmacology & Therapeutics 57 (7), 763-772, 2023 | 16 | 2023 |
| Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase‐4 inhibitor, evogliptin (DA‐1229) J Oh, AHJ Kim, SH Lee, H Cho, YS Kim, MY Bahng, SH Yoon, JY Cho, ... Diabetes, Obesity and Metabolism 19 (2), 294-298, 2017 | 16 | 2017 |
| Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects JG Hwang, SH Lee, W Huh, J Han, J Oh, IJ Jang, KS Yu British Journal of Clinical Pharmacology 88 (9), 4100-4110, 2022 | 15 | 2022 |
| Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants JA Sohn, HS Kim, J Oh, JY Cho, KS Yu, J Lee, SH Shin, JA Lee, CW Choi, ... British Journal of Clinical Pharmacology 83 (6), 1279-1286, 2017 | 14 | 2017 |
| Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans SJ Moon, J Oh, SH Lee, Y Choi, KS Yu, JY Chung Translational and Clinical Pharmacology 26 (2), 79, 2018 | 13 | 2018 |
| A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in … SI Park, H Lee, J Oh, KS Lim, IJ Jang, JA Kim, JH Jung, KS Yu Drug Design, Development and Therapy, 729-736, 2015 | 13 | 2015 |
| A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators H Yoo, SC Ji, JY Cho, SH Kim, JG Yoon, MG Lee, KS Yu, IJ Jang, J Oh Pharmacogenetics and Genomics 31 (3), 68-73, 2021 | 11 | 2021 |
| A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies I Chung, J Oh, SH Lee, IJ Jang, Y Lee, JY Chung Translational and Clinical Pharmacology 26 (1), 6, 2018 | 11 | 2018 |
| Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizers SW Lee, J Oh, AHJ Kim, SC Ji, SI Park, SH Yoon, JY Chung, KS Yu, ... The Pharmacogenomics Journal 20 (6), 792-800, 2020 | 10 | 2020 |
| Utility of integrated analysis of pharmacogenomics and pharmacometabolomics in early phase clinical trial: a case study of a new molecular entity J Oh, S Yi, N Gu, D Shin, KS Yu, SH Yoon, JY Cho, IJ Jang Genomics & informatics 16 (3), 52, 2018 | 10 | 2018 |
